Consistent with the idea that this metabolic activity may be driven by mesenchymal glioma cells enriched in SXO210 explants, the UTSW63, TS516, and HK157 GSC lines expressed low or undetectable levels of the mesenchymal marker CD44 (Figure 6F). This evidence concerns the gene CD44 and central nervous system cancer.